维普中文期刊产品整合服务
28篇 您的检索式:作者名="Hofmann WP"
    题名 作者 年代 出处 被引量
1Severe lactic acidosis during treatment of chronic hepatitis B with entecavir in patients with impaired liver function 显示文摘Lange CM Bojunga J Hofmann WP 2009Hepatology2009,50,6:1
2Viral determinants of resistance to treatment in patients with hepatitis C 显示文摘Wohnsland A Hofmann WP Sarrazin C 2007Clin Microbiol Rev2007,20,1:1
3Dynamics of CD81 expression on lymphocyte subsets during interferon-alpha- based antiviral treatment of patim~ts with chronic hepatitis C显示文摘Kronenberger B Hen'mann E Hofmann WP 2006J Leukoc Bio12006,80,2:1
4Correlation of amino acid variations within nonstructural 4B protein with initial viral kinetics during interferon-alpha-based therapy in HCV-lb-infected patients显示文摘Welker MW Hofmann WP Welsch C 2007J Viral Hepat2007,14,5:1
5Hepatitis Cvirus-related resistance mechanisms to interferon a-based antiviral therapy 显示文摘Hofmann WP Zeuzem St Sarrazin C 2005Clin Virol2005,32,2:1
6Severe lactic acidosisduring treatment of chronic hepatitis B with ente-cavir in patientswith impaired liver显示文摘Lange CM Bojunga J Hofmann WP 0,,06:1
7Prediction of periopera- tire mortality in patients with advanced liver disease and abdominal surgery by the use of different scoring systems and tests 显示文摘Hofmann WP Radle J Moench C 2008Zeitschrift fur Gastmenterologie2008,46,:1
8Current standards in the treatment of chronic hepatitis C 显示文摘Hofmann WP Sarrazin C Zeuzem S 2012Dtsch Arztebl Int2012,109,19:1
9Benefit of 'Freatment Individualization in Patients with Chronic Hepatitis C Receiving Peginterferon Alfa-2a and Ribavirin in a Large Noninterventional Cohort Study显示文摘Hofmann WP Mauss S Lutz T 2015PLoS One2015,10,01:1
10Therapeutic vaccine IC41 as late add-on to standard treatment in patients with chronic hepatitis C 显示文摘Wedemeyer H Schuller E Schlaphoff V Stauber RE Wiegand J Schiefke I Firbas C Jilma B Thursz M Zeuzem S Hofmann WP Hinrichsen H Tauber E Manns MP Klade CS 2009Vaccine2009,27,37:1
11A new standard of care for the treatment of chronic H CV infection 显示文摘Hofmann WP Zeuzem S 2011Nat Rev Gastroenterol Hepatol2011,8,5:1
12ALT screeningfor chronic liver diseases:scrutinizing the evidence显示文摘Wedemeyer H Hofmann WP Lueth S 2010ZGastroenterol2010,48,1:1
13Antiviral therapy of chronic hepatitis C in patients with advanced liver disease and after liver transplantation 显示文摘Peveling -Oberhag J Zeuzem S Hofmann WP 2010Med Microbiol Immunol2010,199,1:1
14Severe lactic acidosis during treatment of chronic hepatitis B with entecavir in patients with impaired liver function显示文摘Lange CM Bojunga J Hofmann WP 0,,:1
15A new standard of care for the treatment of chronic HCV infection 显示文摘HOFMANN WP ZEUZEM S 2011Nat Rev Gastroen- terof Hepatot2011,8,5:1
16Nucleos(t)ide analogue treatment reduces apoptotic activity in patients with chronic hepatitis B显示文摘Farnik H Lange CM Hofmann WP 2011J Clin Virol2011,52,:1
17Role of nucleoside transporters SLC28A2/3 and SLC29A1/2 genetics in ribavirin therapy: protection against anemia in patients with chronic hepatitis C显示文摘Doehring A Hofmann WP Schlecker C 2011Pharrnacogenet Genomlcs2011,21,:1
18ALT screening for chronic liver diseases: scrutinizing the evidence显示文摘Wedemeyer H Hofmann WP Lueth S 2010Gastroenterol2010,348,1:1
19Severe lactic acidosis during treatment of chronic hepatitis B with ente- cavir in patients with impaired liver function显示文摘Lange CM Bojunga J Hofmann WP 2009Hepatolo- gy2009,50,6:1
20Severe lactic acidosis during treatment of chronic hepatitis B with entecavir in patients with impaired liver function显示文摘Lange CM Bojunga J Hofmann WP 2009Hepatology2009,50,:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费